(RTTNews) - Johnson & Johnson (JNJ) released new 52-week Phase 3 results from the ICONIC-TOTAL study evaluating icotrokinra, a first-in-class oral peptide that selectively blocks the IL-23 receptor in ...

Thinning hair is an age-old concern for both men and women, but Millennials and Gen Z around the world seem to be losing ...

Dick Cheney called hunting accident 'one of the worst' days of his life Sam Bankman-Fried, serving 25-year sentence, faces a ...

Trybello has enhanced its Bello Hair Helper Spray, which now features a strengthened botanical blend designed to deliver visibly thicker, ...

Q3 2025 Earnings Call Transcript November 6, 2025 Olaplex Holdings, Inc. reports earnings inline with expectations. Reported ...

Istanbul-based Sule Hair Transplant Clinic has announced the introduction of its Hybrid Sapphire FUE and DHI technique, ...

LONG BEACH, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth” or the "Company"), home to flagship brand Hydrafacial, today announced financial results ...

New results from Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) showed once-daily, oral baricitinib 4 mg helped the majority of adolescent patients (ages 12 to <18) with severe alopecia ...

ZORYVE foam 0.3% was safe, well-tolerated, and demonstrated durable and continuously improving efficacy in the treatment of seborrheic dermatitis ...

Person A is a scalper who resells tickets for concerts and professional baseball games on major ticket sales platforms. A mainly handles performances ...

LONG BEACH, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the appointment of global aesthetics leader, Philippe ...

As of Friday, November 07, The Beauty Health Company’s SKIN share price has surged by 29.46%, which has investors questioning ...